An updated review of target-specific oral anticoagulants used in stroke prevention in atrial fibrillation, venous thromboembolic disease, and acute coronary syndromes.
Christina L Cove et al.
Journal of the American Heart Association, 2(5), e000136-e000136 (2013-10-25)